Results 311 to 320 of about 943,135 (348)
Design and validation of a novel dosimetry phantom for motion management audits
Journal of Applied Clinical Medical Physics, EarlyView.Abstract Background We present a novel phantom design for conducting end‐to‐end dosimetry audits for respiratory motion management of two anatomical treatment sites. The design enables radiochromic film measurements of the dose administered to the target throughout the respiratory cycle (motion‐included) and the dose delivered to the time‐averaged ...
Alex Burton +5 more
wiley +1 more source
Two-way pharmacodynamic modeling of drug combinations and its application to pairs of repurposed Ebola and SARS-CoV-2 agents. [PDF]
Antimicrob Agents ChemotherXu S +6 more
europepmc +1 more source
A Comparison of Three Anesthetic Drug Combinations for Use in Inducing Surgical Anesthesia in Female Guinea Pigs (Cavia porcellus). [PDF]
J Am Assoc Lab Anim SciAvelino JA +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of the American Medical Directors Association, 2005
Caring for the elderly nursing home patient has never been more clinically complex or administratively more troublesome. Patients carry with them a greater burden of disease with increasing frailty and vulnerability. More drugs are being used for more problems.
Barbara J. Zarowitz, Eric G. Tangalos
openaire +3 more sources
Caring for the elderly nursing home patient has never been more clinically complex or administratively more troublesome. Patients carry with them a greater burden of disease with increasing frailty and vulnerability. More drugs are being used for more problems.
Barbara J. Zarowitz, Eric G. Tangalos
openaire +3 more sources
Drug–drug combinations revisited
European Journal of Hospital Pharmacy, 2013The use of fixed-dose combinations (FDCs) in the daily practice of pharmacotherapy is increasing after years in the shadows. The main reasons for this renewed popularity are the increasing number of drugs prescribed per patient and the complexity of current pharmacotherapy.
Bjerrum, Ole Jannik +3 more
openaire +3 more sources
Multiple Sclerosis Journal, 1996
As a result of recent therapeutic trials, recombinant Interferon beta (r/FNβ)-1b and-1a as well as Copolymer 1 (COP 1) and to some extent unspecific immunosuppressants have been accepted as partially efficient treatments of relapsing-remitting MS. In view of partially effective single treatments, the question arises if combination of two or even more ...
openaire +3 more sources
As a result of recent therapeutic trials, recombinant Interferon beta (r/FNβ)-1b and-1a as well as Copolymer 1 (COP 1) and to some extent unspecific immunosuppressants have been accepted as partially efficient treatments of relapsing-remitting MS. In view of partially effective single treatments, the question arises if combination of two or even more ...
openaire +3 more sources
Combination of Antiarrhythmic Drugs
Journal of Cardiovascular Pharmacology, 1991Antiarrhythmic treatment with single agents is often ineffective and can be limited by dose-dependent side effects. Therefore, combinations of antiarrhythmic drugs in smaller and well-tolerated doses are advocated in cases refractory to single antiarrhythmic drugs.
Ralph Mletzko +3 more
openaire +3 more sources